SCLX Q4 2020 Earnings — Scilex Holding Company Revenue & Financial Results | Market Cap Arena

SCLXScilex Holding Company

$73M

Q4 2020 Earnings

Healthcare Drug Manufacturers - General

Income Statement

Revenue

$6M+12.0% YoY

Gross Profit

$5M90.9% margin

Operating Income

-$9M-149.7% margin

Net Income

-$12M-201.7% margin

EPS (Diluted)

$-0.08

QoQ Revenue Growth

+0.0%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$199,484

Total Liabilities

$180,760

Stockholders' Equity

$18,724

Cash & Equivalents

$30,510

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$5M	+12.0%
Gross Profit	$5M	$4M	+40.6%
Operating Income	-$9M	-$35M	+74.6%
Net Income	-$12M	-$45M	+73.4%